Back to Search Start Over

Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.

Authors :
Meschede C
Witt JA
Rademacher M
von Wrede RD
Elger CE
Helmstaedter C
Source :
Seizure [Seizure] 2018 May; Vol. 58, pp. 141-146. Date of Electronic Publication: 2018 Apr 22.
Publication Year :
2018

Abstract

Purpose: This retrospective longitudinal study aims to compare the longer-term cognitive and behavioral side effects of adjunctive antiepileptic treatment with perampanel (PER) and lacosamide (LCM), two third generation antiepileptic drugs with suggested favorable cognitive profiles. The two drugs were monitored according to a previously established routine diagnostic protocol (Helmstaedter et al. E&B 2013;26:182-7) which facilitates the retrospective comparison of antiepileptic drug tolerability in a naturalistic outpatient setting.<br />Methods: Records from 94 patients were evaluated who underwent neuropsychological assessment before and under adjunctive treatment with either PER (n = 57) or LCM (n = 37). Cognition was assessed using the EpiTrack screening for executive functions and a VLMT short form for verbal memory. Subjective assessments included a German QOLIE-10 adaptation (quality of life) and an extended Adverse Events Profile (AEP). The median follow-up interval was 36 weeks.<br />Results: Multivariate repeated measures statistics revealed a non-significant trend towards an interaction effect "time - treatment arm" on both executive function and memory. When analyzed separately executive functions and memory scores significantly improved under LCM (t = -2.76 p < 0.01 and t = -2.44 p < 0.05 respectively). Subjectively, PER was associated with improvements in 2/18 physiological domains and in the LCM group 1/9 cognitive domains deteriorated. Seizure freedom was achieved for five patients treated with LCM (14%) and 15 treated with PER (26%, χ <superscript>2</superscript>  = 2.2, n.s.).<br />Conclusion: In a naturalistic outpatient setting, chronic adjunctive treatment with PER and LCM did not negatively affect cognition and LCM may even improve cognition. Neither drug increased self-reported irritability or aggression. This suggests favorable longer-term tolerability.<br /> (Copyright © 2018 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1532-2688
Volume :
58
Database :
MEDLINE
Journal :
Seizure
Publication Type :
Academic Journal
Accession number :
29704679
Full Text :
https://doi.org/10.1016/j.seizure.2018.04.015